LISDEXAMFETAMINE DIMESYLATE CAPSULES

LISDEXAMFETAMINE DIMESYLATE CAPSULES was reported 5144 times

LISDEXAMFETAMINE DIMESYLATE CAPSULES is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 REMOVAL OF FOREIGN BODY FROM EYE 3 0.2500
1 GAMING DISORDER 3 0.1579
2 CREATINE KINASE ABNORMAL 3 0.1250
3 ANTI-TRANSGLUTAMINASE ANTIBODY INCREASED 7 0.1207
4 STEROID DEPENDENCE 105 0.1196
5 ALCOHOLIC COMA 2 0.1176
6 CATARRH 105 0.1162
7 ORTHODONTIC PROCEDURE 6 0.1111
8 FOCAL MYOSITIS 2 0.1000
9 PREMENSTRUAL DYSPHORIC DISORDER 14 0.0690
10 PROCRASTINATION 3 0.0667
11 SEXUAL INHIBITION 6 0.0645
12 FREE FATTY ACIDS INCREASED 2 0.0606
13 BURNS SECOND DEGREE 106 0.0604
14 INTENTIONAL SELF-INJURY 1028 0.0508
15 ADRENERGIC SYNDROME 4 0.0494
16 ADULTERATED PRODUCT 9 0.0450
17 INABILITY TO AFFORD MEDICATION 399 0.0401
18 FOETAL ALCOHOL SYNDROME 4 0.0400
19 WHITE BLOOD CELLS URINE 11 0.0396
20 PICA 7 0.0389
21 ORGANIC BRAIN SYNDROME 7 0.0372
22 ALCOHOL POISONING 98 0.0366
23 CHANGE IN SUSTAINED ATTENTION 11 0.0365
24 EXECUTIVE DYSFUNCTION 18 0.0332
25 HYPOPNOEA 104 0.0299
26 ACUTE MACULAR NEURORETINOPATHY 5 0.0292
27 SUBCHORIONIC HAEMATOMA 5 0.0284
28 DISRUPTIVE MOOD DYSREGULATION DISORDER 2 0.0270
29 VEIN DISCOLOURATION 12 0.0255
30 POLYDIPSIA PSYCHOGENIC 5 0.0244
31 RABBIT SYNDROME 4 0.0241
32 PRODUCT AVAILABILITY ISSUE 488 0.0214
33 EXCESSIVE EXERCISE 2 0.0211
34 AMNIORRHOEA 4 0.0211
35 SENSORY OVERLOAD 4 0.0203
36 VENTRICULAR DYSKINESIA 4 0.0192
37 DELUSION OF PARASITOSIS 3 0.0191
38 OPSOCLONUS MYOCLONUS 4 0.0188
39 SOCIAL ANXIETY DISORDER 12 0.0183
40 THERAPEUTIC RESPONSE CHANGED 114 0.0180
41 THERAPEUTIC PRODUCT EFFECT VARIABLE 69 0.0178
42 AUTISM SPECTRUM DISORDER 97 0.0176
43 INSURANCE ISSUE 263 0.0172
44 INTENTIONAL OVERDOSE 1060 0.0165
45 HYPNOPOMPIC HALLUCINATION 2 0.0161
46 BODY DYSMORPHIC DISORDER 6 0.0160
47 BINGE EATING 17 0.0158
48 BRONCHIECTASIS 105 0.0156
49 DERMATILLOMANIA 9 0.0151
50 SELF-DESTRUCTIVE BEHAVIOUR 13 0.0149
51 PAROSMIA 106 0.0140
52 ELECTROCARDIOGRAM CHANGE 13 0.0137
53 ACCELERATED IDIOVENTRICULAR RHYTHM 2 0.0135
54 ANISOCORIA 5 0.0132
55 GINGIVAL PAIN 105 0.0132
56 RHINITIS 105 0.0130
57 DEFIANT BEHAVIOUR 4 0.0130
58 SYMPATHOMIMETIC EFFECT 3 0.0130
59 SUSPECTED PRODUCT TAMPERING 7 0.0125
60 CARDIAC MURMUR 106 0.0122
61 MEAN PLATELET VOLUME DECREASED 10 0.0119
62 HYPONATRAEMIC SEIZURE 3 0.0118
63 BOREDOM 4 0.0118
64 ABDOMINAL LYMPHADENOPATHY 10 0.0115
65 NEURODEGENERATIVE DISORDER 7 0.0113
66 TIME PERCEPTION ALTERED 4 0.0110
67 ORTHOSIS USER 3 0.0107
68 THYROXINE FREE DECREASED 6 0.0106
69 THEFT 7 0.0105
70 AVERSION 3 0.0104
71 REGRESSIVE BEHAVIOUR 3 0.0103
72 ATTENTION DEFICIT HYPERACTIVITY DISORDER 43 0.0102
73 OPPOSITIONAL DEFIANT DISORDER 4 0.0101
74 ALCOHOL INTOLERANCE 7 0.0099
75 JOB DISSATISFACTION 6 0.0092
76 SENSITISATION 7 0.0092
77 MITE ALLERGY 6 0.0092
78 DRUG EFFECT FASTER THAN EXPECTED 3 0.0090
79 DRUG TOLERANCE INCREASED 7 0.0090
80 PERINATAL DEPRESSION 4 0.0089
81 GROWTH FAILURE 3 0.0087
82 PRODUCT MONITORING ERROR 12 0.0083
83 BACTERIAL DISEASE CARRIER 6 0.0082
84 MONOCYTE COUNT DECREASED 10 0.0082
85 WATER INTOXICATION 4 0.0079
86 SUICIDE THREAT 3 0.0077
87 CHILLBLAINS 2 0.0077
88 INTRUSIVE THOUGHTS 9 0.0076
89 IMPAIRED QUALITY OF LIFE 105 0.0073
90 INTELLECTUAL DISABILITY 11 0.0072
91 DISORGANISED SPEECH 13 0.0070
92 BURNOUT SYNDROME 4 0.0070
93 MULTIPLE ACYL-COENZYME A DEHYDROGENASE DEFICIENCY 3 0.0070
94 TRICHOTILLOMANIA 4 0.0068
95 SEXUAL ABUSE 3 0.0068
96 DECREASED EYE CONTACT 2 0.0066
97 PRODUCT SUBSTITUTION ISSUE 369 0.0064
98 NARCOLEPSY 12 0.0064
99 PLICATED TONGUE 3 0.0063
100 EMOTIONAL POVERTY 11 0.0063
101 FOREIGN BODY IN EYE 6 0.0063
102 DREAMY STATE 2 0.0062
103 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 10 0.0060
104 IMPAIRED WORK ABILITY 128 0.0060
105 TUBULOINTERSTITIAL NEPHRITIS 111 0.0059
106 EOSINOPHILIC PNEUMONIA ACUTE 5 0.0058
107 MALE ORGASMIC DISORDER 3 0.0058
108 HEART RATE 2 0.0057
109 HEMIHYPOAESTHESIA 2 0.0057
110 DISSOCIATIVE DISORDER 4 0.0055
111 AMPHETAMINES POSITIVE 4 0.0053
112 ENCEPHALITIS AUTOIMMUNE 7 0.0053
113 IMPAIRED REASONING 2 0.0052
114 CARDIOVASCULAR SYMPTOM 2 0.0052
115 PRODUCT PHYSICAL ISSUE 104 0.0052
116 CONGENITAL DIAPHRAGMATIC HERNIA 2 0.0051
117 BLUE TOE SYNDROME 2 0.0051
118 FOOD INTERACTION 9 0.0051
119 IMPULSIVE BEHAVIOUR 19 0.0051
120 DRUG EFFECT LESS THAN EXPECTED 74 0.0050
121 CULTURE URINE POSITIVE 7 0.0050
122 HEAT EXHAUSTION 4 0.0050
123 TIC 27 0.0049
124 SUSPECTED PRODUCT QUALITY ISSUE 9 0.0049
125 BRAIN FOG 76 0.0048
126 NEAR DEATH EXPERIENCE 16 0.0048
127 DRUG WITHDRAWAL HEADACHE 2 0.0048
128 KNEE DEFORMITY 7 0.0047
129 ACTIVITIES OF DAILY LIVING DECREASED 3 0.0047
130 HEAT STROKE 7 0.0046
131 CARDIAC OUTPUT DECREASED 4 0.0045
132 SPUTUM ABNORMAL 3 0.0045
133 COMPULSIONS 3 0.0045
134 FEELING OF DESPAIR 21 0.0045
135 HYPERSEXUALITY 8 0.0044
136 DISTURBANCE IN SEXUAL AROUSAL 4 0.0043
137 HAND DERMATITIS 3 0.0043
138 HYPERPHAGIA 17 0.0043
139 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 201 0.0042
140 ORTHOSTATIC INTOLERANCE 3 0.0042
141 PATIENT DISSATISFACTION WITH TREATMENT 8 0.0041
142 FREQUENT BOWEL MOVEMENTS 111 0.0041
143 INDIFFERENCE 3 0.0040
144 DILATED CARDIOMYOPATHY 4 0.0040
145 ABORTION MISSED 5 0.0039
146 CENTRAL NERVOUS SYSTEM VASCULITIS 2 0.0039
147 IMPULSE-CONTROL DISORDER 8 0.0039
148 LABORATORY TEST INTERFERENCE 3 0.0038
149 DRUG TOLERANCE 19 0.0038
150 SWOLLEN TONGUE 117 0.0037
151 DISTURBANCE IN ATTENTION 202 0.0037
152 VULVOVAGINAL CANDIDIASIS 5 0.0037
153 HYPERTENSIVE URGENCY 2 0.0036
154 EDUCATIONAL PROBLEM 6 0.0036
155 ELECTRIC SHOCK SENSATION 10 0.0036
156 STRESS AT WORK 4 0.0035
157 BRUXISM 19 0.0035
158 METABOLIC SURGERY 4 0.0035
159 HAEMORRHAGE IN PREGNANCY 5 0.0035
160 SERUM FERRITIN DECREASED 6 0.0035
161 DISTRACTIBILITY 4 0.0035
162 VASOCONSTRICTION 3 0.0034
163 APATHY 50 0.0034
164 IRREGULAR BREATHING 2 0.0034
165 TOBACCO USER 5 0.0034
166 BLOOD IMMUNOGLOBULIN G INCREASED 4 0.0033
167 NIGHTMARE 112 0.0032
168 SUBSTANCE USE 5 0.0032
169 HYPERVIGILANCE 3 0.0031
170 SYSTEMIC LUPUS ERYTHEMATOSUS 109 0.0031
171 COUNTERFEIT PRODUCT ADMINISTERED 4 0.0031
172 POISONING DELIBERATE 29 0.0031
173 ACCIDENTAL OVERDOSE 110 0.0030
174 ANTISOCIAL BEHAVIOUR 3 0.0030
175 CHOREOATHETOSIS 2 0.0029
176 CENTRAL SEROUS CHORIORETINOPATHY 2 0.0029
177 CUTANEOUS SYMPTOM 2 0.0029
178 STRESS CARDIOMYOPATHY 17 0.0029
179 FEELING OF RELAXATION 2 0.0029
180 PREMENSTRUAL SYNDROME 4 0.0029
181 PRODUCT FORMULATION ISSUE 19 0.0029
182 MAST CELL ACTIVATION SYNDROME 4 0.0028
183 DEPRESSIVE SYMPTOM 10 0.0028
184 BORDERLINE PERSONALITY DISORDER 2 0.0028
185 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 3 0.0028
186 PNEUMOMEDIASTINUM 5 0.0028
187 BIPOLAR DISORDER 30 0.0028
188 JUDGEMENT IMPAIRED 4 0.0028
189 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 17 0.0027
190 IRRITABILITY 164 0.0027
191 TRISMUS 14 0.0027
192 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 6 0.0027
193 FACIAL SPASM 3 0.0027
194 LOSS OF EMPLOYMENT 8 0.0026
195 CHROMATOPSIA 2 0.0026
196 TINNITUS 121 0.0026
197 MEDICATION ERROR 146 0.0026
198 DISSOCIATION 20 0.0026
199 PREMATURE SEPARATION OF PLACENTA 4 0.0026
200 FLAT AFFECT 6 0.0026
201 RECTAL HAEMORRHAGE 111 0.0026
202 THERAPEUTIC PRODUCT EFFECT INCREASED 3 0.0026
203 DISCOURAGEMENT 6 0.0026
204 JAW DISORDER 14 0.0026
205 LOGORRHOEA 9 0.0026
206 SUSPECTED COUNTERFEIT PRODUCT 10 0.0025
207 ALLERGIC REACTION TO EXCIPIENT 5 0.0025
208 PULSE ABNORMAL 6 0.0025
209 FRUSTRATION TOLERANCE DECREASED 20 0.0025
210 EUPHORIC MOOD 25 0.0024
211 COLITIS ULCERATIVE 109 0.0024
212 PSYCHOTIC SYMPTOM 5 0.0024
213 HYPERACUSIS 9 0.0024
214 RED CELL DISTRIBUTION WIDTH INCREASED 10 0.0024
215 TROPONIN I INCREASED 4 0.0024
216 NEGATIVE THOUGHTS 7 0.0024
217 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 3 0.0024
218 ECZEMA 124 0.0024
219 SLEEP DEFICIT 5 0.0024
220 PRODUCT COUNTERFEIT 4 0.0023
221 SUICIDAL IDEATION 209 0.0023
222 DRUG SCREEN NEGATIVE 4 0.0023
223 PRODUCT TAMPERING 4 0.0022
224 FEAR OF DEATH 5 0.0022
225 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 3 0.0022
226 BEHAVIOUR DISORDER 12 0.0022
227 ANORGASMIA 6 0.0022
228 THERAPEUTIC PRODUCT EFFECT DELAYED 10 0.0022
229 AFFECT LABILITY 21 0.0022
230 HYPOMANIA 8 0.0022
231 PERSONALITY CHANGE 20 0.0022
232 SELF-INJURIOUS IDEATION 9 0.0021
233 HAEMATOCHEZIA 118 0.0021
234 SUSPECTED SUICIDE 10 0.0021
235 SEXUAL DYSFUNCTION 25 0.0021
236 CARDIAC FAILURE ACUTE 14 0.0021
237 HYPERCOAGULATION 4 0.0021
238 SEROTONIN SYNDROME 40 0.0021
239 GENERALISED ANXIETY DISORDER 3 0.0020
240 UNDERWEIGHT 4 0.0020
241 TACHYPHRENIA 7 0.0020
242 HYPERREFLEXIA 7 0.0020
243 OBSESSIVE-COMPULSIVE DISORDER 16 0.0020
244 GASTRECTOMY 2 0.0020
245 PSYCHOMOTOR HYPERACTIVITY 33 0.0020
246 DEPRESSED MOOD 104 0.0020
247 DAYDREAMING 3 0.0019
248 POLYCYSTIC OVARIES 3 0.0019
249 PERFORMANCE STATUS DECREASED 9 0.0019
250 VERTIGO 117 0.0019
251 AKATHISIA 26 0.0019
252 PALPITATIONS 222 0.0019
253 INAPPROPRIATE AFFECT 3 0.0019
254 ANGER 64 0.0019
255 DROOLING 13 0.0019
256 MYDRIASIS 24 0.0019
257 TEARFULNESS 8 0.0019
258 BLADDER DILATATION 2 0.0018
259 ARRHYTHMIA SUPRAVENTRICULAR 2 0.0018
260 ACARODERMATITIS 2 0.0018
261 METABOLIC SYNDROME 3 0.0018
262 AFFECTIVE DISORDER 14 0.0018
263 EROSIVE OESOPHAGITIS 3 0.0018
264 FOOD AVERSION 3 0.0018
265 ECTOPIC PREGNANCY WITH CONTRACEPTIVE DEVICE 3 0.0018
266 LAZINESS 3 0.0018
267 CEREBRAL ATROPHY 7 0.0018
268 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 9 0.0018
269 HAIR GROWTH ABNORMAL 12 0.0017
270 VITAMIN B12 DEFICIENCY 7 0.0017
271 AGGRESSION 85 0.0017
272 SOCIAL PROBLEM 7 0.0017
273 SUICIDAL BEHAVIOUR 7 0.0017
274 REBOUND EFFECT 19 0.0017
275 DEEP VEIN THROMBOSIS 109 0.0017
276 APPETITE DISORDER 11 0.0017
277 CRANIOCEREBRAL INJURY 5 0.0017
278 HUNGER 23 0.0016
279 AGITATION 120 0.0016
280 PUPILLARY REFLEX IMPAIRED 3 0.0016
281 LYMPH NODE PAIN 3 0.0016
282 CARDIAC DYSFUNCTION 6 0.0016
283 TUNNEL VISION 3 0.0016
284 SUICIDE ATTEMPT 97 0.0016
285 IMPATIENCE 3 0.0016
286 MANIA 26 0.0016
287 MIGRAINE 149 0.0016
288 HEAVY MENSTRUAL BLEEDING 14 0.0016
289 SINUS TACHYCARDIA 22 0.0015
290 PRODUCT SUPPLY ISSUE 11 0.0015
291 ADJUSTMENT DISORDER 2 0.0015
292 NASAL SEPTUM DEVIATION 3 0.0015
293 PERSONALITY DISORDER 4 0.0015
294 PANIC REACTION 11 0.0015
295 DYSGEUSIA 113 0.0015
296 POOR QUALITY PRODUCT ADMINISTERED 16 0.0015
297 POLYDIPSIA 6 0.0015
298 THERAPEUTIC RESPONSE DECREASED 92 0.0015
299 FEELING GUILTY 2 0.0015
300 GASTRITIS EROSIVE 7 0.0015
301 CARDIAC DISCOMFORT 3 0.0015
302 LIBIDO INCREASED 3 0.0015
303 AGORAPHOBIA 2 0.0015
304 DRUG DIVERSION 9 0.0015
305 THERAPEUTIC RESPONSE SHORTENED 48 0.0014
306 POLYMENORRHOEA 5 0.0014
307 INSULIN RESISTANCE 3 0.0014
308 HALLUCINATIONS, MIXED 6 0.0014
309 HANGOVER 5 0.0014
310 STATUS EPILEPTICUS 16 0.0014
311 GLUTEN SENSITIVITY 2 0.0014
312 THINKING ABNORMAL 26 0.0014
313 DEREALISATION 3 0.0014
314 SOCIAL AVOIDANT BEHAVIOUR 8 0.0014
315 ADVERSE DRUG REACTION 124 0.0014
316 METABOLIC DISORDER 8 0.0014
317 RESTLESS LEGS SYNDROME 25 0.0014
318 ARTHRITIS 108 0.0014
319 UTERINE LEIOMYOMA 10 0.0014
320 PRODUCT COLOUR ISSUE 7 0.0014
321 ACCIDENT AT WORK 3 0.0014
322 DEPRESSION 308 0.0014
323 PRODUCT LOT NUMBER ISSUE 3 0.0014
324 THERAPEUTIC PRODUCT EFFECT DECREASED 60 0.0013
325 METABOLIC ENCEPHALOPATHY 4 0.0013
326 INTENTIONAL PRODUCT USE ISSUE 115 0.0013
327 FEELING JITTERY 25 0.0013
328 PSYCHOTIC DISORDER 38 0.0013
329 EPSTEIN-BARR VIRUS INFECTION 8 0.0013
330 PANCREATITIS CHRONIC 3 0.0013
331 IRIDOCYCLITIS 4 0.0013
332 INHIBITORY DRUG INTERACTION 2 0.0013
333 HEART RATE ABNORMAL 7 0.0013
334 PRODUCT USE ISSUE 235 0.0012
335 WEIGHT ABNORMAL 3 0.0012
336 ANGIOPATHY 7 0.0012
337 ARTERIOSPASM CORONARY 5 0.0012
338 LEARNING DISORDER 3 0.0012
339 CYSTITIS INTERSTITIAL 2 0.0012
340 SELF ESTEEM DECREASED 3 0.0012
341 PERIPHERAL COLDNESS 17 0.0012
342 VULVOVAGINAL DRYNESS 4 0.0012
343 MUSCLE TIGHTNESS 20 0.0012
344 BREATH ODOUR 3 0.0012
345 NEUTROPHILIA 7 0.0012
346 PERSECUTORY DELUSION 3 0.0012
347 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 215 0.0012
348 TONGUE DISCOMFORT 5 0.0012
349 NEUTROPHIL COUNT INCREASED 12 0.0012
350 VITAMIN D DECREASED 10 0.0012
351 WITHDRAWAL SYNDROME 49 0.0012
352 KIDNEY FIBROSIS 2 0.0012
353 SOMNOLENCE 232 0.0012
354 MALABSORPTION 6 0.0011
355 PULMONARY EMBOLISM 109 0.0011
356 PRODUCT ADMINISTRATION INTERRUPTED 9 0.0011
357 ALOPECIA AREATA 2 0.0011
358 MUSCLE CONTRACTIONS INVOLUNTARY 4 0.0011
359 MENTAL DISORDER 49 0.0011
360 YAWNING 3 0.0011
361 DISABILITY 22 0.0011
362 GAMBLING DISORDER 3 0.0011
363 ANXIETY 316 0.0011
364 CLUMSINESS 3 0.0011
365 MAJOR DEPRESSION 8 0.0011
366 PLEURITIC PAIN 3 0.0011
367 BODY TEMPERATURE ABNORMAL 2 0.0011
368 MUSCLE TWITCHING 25 0.0011
369 CONFUSIONAL STATE 175 0.0011
370 SLUGGISHNESS 11 0.0011
371 COORDINATION ABNORMAL 15 0.0011
372 CRYING 39 0.0011
373 AUTOIMMUNE THYROIDITIS 4 0.0011
374 COMMUNICATION DISORDER 4 0.0010
375 POISONING 13 0.0010
376 PANIC DISORDER 4 0.0010
377 PRODUCT LABEL ISSUE 7 0.0010
378 MOOD ALTERED 28 0.0010
379 ABDOMINAL WALL HAEMATOMA 2 0.0010
380 BRADYKINESIA 6 0.0010
381 GLUCOSE TOLERANCE IMPAIRED 6 0.0010
382 RESTLESSNESS 37 0.0010
383 ABNORMAL BEHAVIOUR 40 0.0010
384 FORMICATION 7 0.0010
385 EMOTIONAL DISORDER 31 0.0010
386 HEPATIC ENZYME ABNORMAL 5 0.0010
387 MIOSIS 8 0.0010
388 PRODUCT SOLUBILITY ABNORMAL 5 0.0010
389 MENTAL IMPAIRMENT 24 0.0010
390 DYSPHORIA 5 0.0010
391 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 6 0.0010
392 PARANOIA 17 0.0010
393 CHANGE OF BOWEL HABIT 2 0.0010
394 PRODUCT TEMPERATURE EXCURSION ISSUE 5 0.0010
395 MOOD SWINGS 31 0.0010
396 QUALITY OF LIFE DECREASED 13 0.0010
397 TACHYCARDIA 86 0.0010
398 PHARYNGITIS 12 0.0010
399 DELUSION 15 0.0010
400 ATRIAL TACHYCARDIA 2 0.0010
401 EXOPHTHALMOS 2 0.0009
402 PLATELET COUNT INCREASED 12 0.0009
403 DYSPHEMIA 4 0.0009
404 BIPOLAR I DISORDER 2 0.0009
405 LISTLESS 3 0.0009
406 SCHIZOPHRENIA 11 0.0009
407 HYPERTHYROIDISM 13 0.0009
408 ILEUS PARALYTIC 4 0.0009
409 INTERMENSTRUAL BLEEDING 5 0.0009
410 SLEEP DISORDER 63 0.0009
411 FEAR 24 0.0009
412 HYPOTHERMIA 9 0.0009
413 HALLUCINATION, AUDITORY 14 0.0009
414 PANIC ATTACK 32 0.0009
415 MICTURITION URGENCY 10 0.0009
416 UNEVALUABLE EVENT 66 0.0009
417 PRIAPISM 3 0.0009
418 DEPRESSION SUICIDAL 3 0.0009
419 MOUTH SWELLING 5 0.0009
420 ARRHYTHMIA 41 0.0009
421 CONDITION AGGRAVATED 262 0.0009
422 THERAPY INTERRUPTED 61 0.0009
423 DISTURBANCE IN SOCIAL BEHAVIOUR 2 0.0008
424 MYOCLONUS 10 0.0008
425 INCREASED APPETITE 16 0.0008
426 TYPE 1 DIABETES MELLITUS 5 0.0008
427 MONOCYTE COUNT INCREASED 3 0.0008
428 ABDOMINAL DISCOMFORT 137 0.0008
429 ACUTE PSYCHOSIS 2 0.0008
430 COVID-19 141 0.0008
431 DRY MOUTH 65 0.0008
432 HEART RATE INCREASED 79 0.0008
433 COLD SWEAT 14 0.0008
434 BLEPHAROSPASM 5 0.0008
435 SNORING 3 0.0008
436 INSOMNIA 210 0.0008
437 HYPERTHERMIA 6 0.0008
438 FEELING ABNORMAL 188 0.0008
439 INITIAL INSOMNIA 8 0.0008
440 URINARY INCONTINENCE 23 0.0008
441 FAECES HARD 3 0.0008
442 FOOD CRAVING 4 0.0008
443 PRODUCT DISTRIBUTION ISSUE 7 0.0008
444 POOR QUALITY SLEEP 16 0.0007
445 HOMICIDAL IDEATION 3 0.0007
446 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 5 0.0007
447 ACUTE HEPATIC FAILURE 10 0.0007
448 INFARCTION 5 0.0007
449 HYPERAESTHESIA 6 0.0007
450 APHASIA 22 0.0007
451 PRODUCT PHYSICAL CONSISTENCY ISSUE 4 0.0007
452 ENCEPHALITIS 5 0.0007
453 EOSINOPHILIC OESOPHAGITIS 2 0.0007
454 CEREBROVASCULAR ACCIDENT 122 0.0007
455 STREPTOCOCCAL INFECTION 4 0.0007
456 DRUG TOLERANCE DECREASED 2 0.0007
457 PAIN IN JAW 20 0.0007
458 THERAPY PARTIAL RESPONDER 11 0.0007
459 ALCOHOLISM 3 0.0007
460 TENSION HEADACHE 3 0.0007
461 DYSPNOEA AT REST 2 0.0007
462 DRUG INTERACTION 109 0.0007
463 BLOOD PARATHYROID HORMONE INCREASED 2 0.0007
464 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
465 LYMPHOCYTE COUNT DECREASED 12 0.0007
466 PRODUCT USE IN UNAPPROVED INDICATION 168 0.0007
467 HEAD DISCOMFORT 12 0.0007
468 BLOOD CREATINE INCREASED 3 0.0007
469 WEIGHT DECREASED 188 0.0007
470 ACNE CYSTIC 2 0.0007
471 TENSION 4 0.0007
472 DRUG INEFFECTIVE 856 0.0006
473 PREGNANCY 13 0.0006
474 SEDATION 17 0.0006
475 CIRCULATORY COLLAPSE 11 0.0006
476 ROSACEA 3 0.0006
477 PRODUCT QUALITY ISSUE 87 0.0006
478 MULTIPLE ALLERGIES 5 0.0006
479 BLOOD PROLACTIN INCREASED 3 0.0006
480 SEASONAL ALLERGY 9 0.0006
481 FOREIGN BODY IN THROAT 2 0.0006
482 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
483 URINARY RETENTION 21 0.0006
484 ENDOMETRIOSIS 3 0.0006
485 HYPERSOMNIA 18 0.0006
486 GALACTORRHOEA 4 0.0006
487 EPILEPSY 19 0.0006
488 CARDIAC FLUTTER 4 0.0006
489 HYPERPROLACTINAEMIA 4 0.0006
490 IMPAIRED DRIVING ABILITY 7 0.0006
491 HEADACHE 386 0.0006
492 COELIAC DISEASE 6 0.0006
493 PRODUCT PREPARATION ISSUE 4 0.0006
494 EXTRAPYRAMIDAL DISORDER 15 0.0006
495 EAR INFECTION 16 0.0006
496 ANXIETY DISORDER 2 0.0006
497 BRAIN INJURY 6 0.0006
498 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
499 FEEDING DISORDER 12 0.0006
500 ERECTILE DYSFUNCTION 15 0.0006
501 TEMPERATURE INTOLERANCE 6 0.0006
502 CERVICAL VERTEBRAL FRACTURE 2 0.0006
503 PRODUCT ODOUR ABNORMAL 6 0.0006
504 AMENORRHOEA 10 0.0006
505 OBESITY 9 0.0006
506 GLOSSITIS 2 0.0006
507 CARDIOGENIC SHOCK 8 0.0006
508 COGNITIVE DISORDER 26 0.0006
509 LETHARGY 32 0.0006
510 ELECTROCARDIOGRAM QT PROLONGED 20 0.0006
511 ANAL INCONTINENCE 5 0.0006
512 DRUG ABUSE 46 0.0006
513 ALCOHOL USE 2 0.0005
514 DYSKINESIA 22 0.0005
515 HYPERTENSIVE CRISIS 6 0.0005
516 FEELING DRUNK 4 0.0005
517 LYMPHADENOPATHY 19 0.0005
518 HYPERHIDROSIS 69 0.0005
519 BEDRIDDEN 7 0.0005
520 PHOTOPHOBIA 10 0.0005
521 DYSMENORRHOEA 7 0.0005
522 TOXICITY TO VARIOUS AGENTS 89 0.0005
523 DERMATITIS 11 0.0005
524 NERVOUSNESS 27 0.0005
525 EATING DISORDER 11 0.0005
526 DRUG DEPENDENCE 83 0.0005
527 FATIGUE 400 0.0005
528 AUTOIMMUNE DISORDER 5 0.0005
529 SYNCOPE 51 0.0005
530 ENERGY INCREASED 3 0.0005
531 RESPIRATORY ARREST 14 0.0005
532 HAEMATOCRIT DECREASED 10 0.0005
533 DECREASED APPETITE 117 0.0005
534 ORAL DISCOMFORT 7 0.0005
535 SYMPTOM RECURRENCE 3 0.0005
536 DRUG INTOLERANCE 48 0.0005
537 GAMMA-GLUTAMYLTRANSFERASE INCREASED 11 0.0005
538 FUNGAL SKIN INFECTION 2 0.0005
539 SUBSTANCE ABUSE 4 0.0005
540 LIMB DISCOMFORT 15 0.0005
541 DISORIENTATION 19 0.0005
542 DRUG-INDUCED LIVER INJURY 15 0.0005
543 DRUG USE DISORDER 4 0.0005
544 HEPATIC PAIN 2 0.0005
545 PRODUCT PRESCRIBING ERROR 11 0.0005
546 MEMORY IMPAIRMENT 63 0.0005
547 PAIN IN EXTREMITY 135 0.0005
548 OESOPHAGITIS 5 0.0005
549 ASPIRATION 5 0.0005
550 GASTROINTESTINAL PAIN 5 0.0005
551 PRESYNCOPE 11 0.0005
552 FOOT DEFORMITY 5 0.0005
553 MENINGITIS 3 0.0004
554 POST-TRAUMATIC STRESS DISORDER 3 0.0004
555 LOSS OF CONSCIOUSNESS 57 0.0004
556 LOSS OF LIBIDO 4 0.0004
557 PRODUCT TASTE ABNORMAL 6 0.0004
558 TACHYPNOEA 6 0.0004
559 ABNORMAL LOSS OF WEIGHT 3 0.0004
560 IMMUNE THROMBOCYTOPENIA 2 0.0004
561 HAEMATEMESIS 11 0.0004
562 AUTOIMMUNE HEPATITIS 3 0.0004
563 PYREXIA 149 0.0004
564 VISION BLURRED 59 0.0004
565 HALLUCINATION, VISUAL 9 0.0004
566 HALLUCINATION 32 0.0004
567 PHOTOSENSITIVITY REACTION 7 0.0004
568 GENERALISED TONIC-CLONIC SEIZURE 7 0.0004
569 PRODUCT PACKAGING ISSUE 4 0.0004
570 SPEECH DISORDER 22 0.0004
571 MUSCLE RIGIDITY 5 0.0004
572 ORAL DISORDER 3 0.0004
573 INCORRECT DOSAGE ADMINISTERED 2 0.0004
574 SCAR 7 0.0004
575 PHARYNGEAL SWELLING 4 0.0004
576 THERAPY CHANGE 4 0.0004
577 BODY TEMPERATURE DECREASED 4 0.0004
578 SUNBURN 3 0.0004
579 CHEST DISCOMFORT 41 0.0004
580 SALIVARY HYPERSECRETION 4 0.0004
581 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
582 ECONOMIC PROBLEM 6 0.0004
583 NECK PAIN 22 0.0004
584 THIRST 7 0.0004
585 SKIN DISCOLOURATION 18 0.0004
586 MATERNAL DRUGS AFFECTING FOETUS 3 0.0004
587 INCREASED UPPER AIRWAY SECRETION 2 0.0004
588 CONCUSSION 3 0.0004
589 INTENTIONAL DOSE OMISSION 11 0.0004
590 NICOTINE DEPENDENCE 3 0.0004
591 FOETAL DEATH 2 0.0004
592 APNOEA 3 0.0004
593 CYANOSIS 6 0.0004
594 BLOOD GLUCOSE ABNORMAL 7 0.0004
595 JOINT DISLOCATION 4 0.0004
596 PREMATURE DELIVERY 6 0.0004
597 SENSORY DISTURBANCE 6 0.0004
598 MATERNAL EXPOSURE DURING PREGNANCY 33 0.0004
599 AMNESIA 24 0.0004
600 PRODUCT DISPENSING ERROR 8 0.0004
601 PRODUCT PRESCRIBING ISSUE 8 0.0004
602 ASTHENOPIA 2 0.0004
603 VENTRICULAR TACHYCARDIA 6 0.0004
604 DEAFNESS UNILATERAL 2 0.0004
605 INTRACRANIAL PRESSURE INCREASED 2 0.0004
606 THERAPEUTIC RESPONSE UNEXPECTED 16 0.0004
607 RED BLOOD CELL COUNT DECREASED 10 0.0003
608 PARALYSIS 5 0.0003
609 EXERCISE TOLERANCE DECREASED 2 0.0003
610 BLOOD PRESSURE DECREASED 23 0.0003
611 HYPERVENTILATION 2 0.0003
612 ORTHOSTATIC HYPOTENSION 6 0.0003
613 BODY TEMPERATURE INCREASED 7 0.0003
614 ILLNESS 35 0.0003
615 LACTIC ACIDOSIS 11 0.0003
616 DECREASED INTEREST 2 0.0003
617 ACCIDENT 4 0.0003
618 OROPHARYNGEAL PAIN 31 0.0003
619 ROAD TRAFFIC ACCIDENT 14 0.0003
620 BLOOD PRESSURE FLUCTUATION 8 0.0003
621 RASH 145 0.0003
622 HYPOAESTHESIA ORAL 5 0.0003
623 SEIZURE 38 0.0003
624 FOETAL GROWTH RESTRICTION 2 0.0003
625 BRAIN NEOPLASM 3 0.0003
626 NO ADVERSE EVENT 59 0.0003
627 DRUG ABUSER 2 0.0003
628 TREMOR 54 0.0003
629 HYPOKALAEMIA 15 0.0003
630 DIZZINESS 161 0.0003
631 DIARRHOEA HAEMORRHAGIC 3 0.0003
632 EXTRA DOSE ADMINISTERED 13 0.0003
633 ABORTION INDUCED 3 0.0003
634 ADVERSE EVENT 29 0.0003
635 FOREIGN BODY SENSATION IN EYES 2 0.0003
636 HYPOTHYROIDISM 10 0.0003
637 GASTROINTESTINAL DISORDER 28 0.0003
638 PRESCRIBED OVERDOSE 6 0.0003
639 HEART RATE IRREGULAR 7 0.0003
640 DIZZINESS POSTURAL 3 0.0003
641 INCOHERENT 2 0.0003
642 ANGINA UNSTABLE 2 0.0003
643 BLOOD PRESSURE INCREASED 47 0.0003
644 OFF LABEL USE 269 0.0003
645 BRADYPHRENIA 2 0.0003
646 CHEST PAIN 56 0.0003
647 C-REACTIVE PROTEIN INCREASED 11 0.0003
648 BLADDER DISORDER 3 0.0003
649 BLOOD CHOLESTEROL INCREASED 14 0.0003
650 VAGINAL HAEMORRHAGE 13 0.0003
651 ABORTION SPONTANEOUS 12 0.0003
652 MENSTRUATION IRREGULAR 8 0.0003
653 COLITIS ISCHAEMIC 2 0.0003
654 DRY THROAT 3 0.0003
655 DRUG LEVEL DECREASED 3 0.0003
656 WEIGHT INCREASED 66 0.0003
657 EYE MOVEMENT DISORDER 2 0.0003
658 VENTRICULAR EXTRASYSTOLES 3 0.0003
659 FIBROMYALGIA 7 0.0003
660 HYPERTRANSAMINASAEMIA 2 0.0003
661 CEREBRAL INFARCTION 7 0.0003
662 EXTRASYSTOLES 2 0.0003
663 SKIN REACTION 4 0.0003
664 FULL BLOOD COUNT ABNORMAL 3 0.0003
665 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
666 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 20 0.0003
667 MOVEMENT DISORDER 9 0.0003
668 ANGINA PECTORIS 8 0.0003
669 DECREASED ACTIVITY 3 0.0003
670 PHARYNGITIS STREPTOCOCCAL 3 0.0003
671 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
672 GASTROENTERITIS VIRAL 5 0.0003
673 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 56 0.0003
674 HYPOKINESIA 4 0.0003
675 MELAENA 6 0.0003
676 HYPOPHOSPHATAEMIA 2 0.0003
677 MYALGIA 46 0.0003
678 CEREBRAL DISORDER 2 0.0003
679 MIDDLE INSOMNIA 5 0.0003
680 OCULAR DISCOMFORT 3 0.0003
681 ANHEDONIA 7 0.0003
682 PAIN 162 0.0003
683 SLEEP APNOEA SYNDROME 5 0.0003
684 MYOCARDITIS 3 0.0003
685 BOWEL MOVEMENT IRREGULARITY 2 0.0003
686 FEELING HOT 16 0.0003
687 GLAUCOMA 5 0.0003
688 FOOD ALLERGY 2 0.0003
689 ERUCTATION 5 0.0003
690 ANKLE FRACTURE 4 0.0003
691 APHTHOUS ULCER 2 0.0003
692 PALLOR 7 0.0003
693 EAR PAIN 5 0.0003
694 DYSPHONIA 15 0.0003
695 CHOKING 5 0.0003
696 SPINAL PAIN 3 0.0003
697 TREATMENT NONCOMPLIANCE 14 0.0003
698 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
699 PRODUCT USE COMPLAINT 4 0.0003
700 HYPOAESTHESIA 38 0.0003
701 INTENTIONAL PRODUCT MISUSE 22 0.0003
702 PRODUCT ADMINISTRATION ERROR 5 0.0002
703 MULTIPLE ORGAN DYSFUNCTION SYNDROME 7 0.0002
704 NAUSEA 195 0.0002
705 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
706 EMBOLISM 2 0.0002
707 LEUKOPENIA 12 0.0002
708 DYSARTHRIA 9 0.0002
709 MOUTH ULCERATION 5 0.0002
710 CARDIOVASCULAR DISORDER 6 0.0002
711 HEPATITIS 6 0.0002
712 LACRIMATION INCREASED 7 0.0002
713 HYPERTENSION 49 0.0002
714 RESPIRATORY TRACT INFECTION 6 0.0002
715 NODULE 3 0.0002
716 GASTRITIS 6 0.0002
717 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
718 NERVOUS SYSTEM DISORDER 7 0.0002
719 ISCHAEMIC STROKE 4 0.0002
720 FACIAL PAIN 2 0.0002
721 GLOSSODYNIA 5 0.0002
722 ORAL PAIN 5 0.0002
723 PANCREATITIS ACUTE 5 0.0002
724 THROAT TIGHTNESS 6 0.0002
725 HEAD INJURY 7 0.0002
726 HIDRADENITIS 2 0.0002
727 CARDIAC ARREST 18 0.0002
728 CONJUNCTIVITIS 4 0.0002
729 HEPATIC STEATOSIS 4 0.0002
730 WOUND 6 0.0002
731 APPENDICITIS 2 0.0002
732 ABDOMINAL PAIN UPPER 44 0.0002
733 CHOLELITHIASIS 7 0.0002
734 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
735 FOOT FRACTURE 4 0.0002
736 EYE INFLAMMATION 2 0.0002
737 EXPOSURE DURING PREGNANCY 13 0.0002
738 OVERDOSE 45 0.0002
739 BALANCE DISORDER 18 0.0002
740 PARAESTHESIA ORAL 3 0.0002
741 ACUTE RESPIRATORY FAILURE 4 0.0002
742 EMOTIONAL DISTRESS 25 0.0002
743 ABDOMINAL PAIN 48 0.0002
744 DYSTONIA 4 0.0002
745 TREATMENT FAILURE 17 0.0002
746 HAEMORRHOIDS 4 0.0002
747 ENCEPHALOPATHY 5 0.0002
748 MALAISE 89 0.0002
749 SKIN HAEMORRHAGE 3 0.0002
750 DELIRIUM 7 0.0002
751 BLOOD PRESSURE ABNORMAL 4 0.0002
752 HEART RATE DECREASED 7 0.0002
753 ANAPHYLACTIC REACTION 11 0.0002
754 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
755 ACNE 15 0.0002
756 OSTEOPENIA 3 0.0002
757 PRODUCT DOSE OMISSION ISSUE 58 0.0002
758 TASTE DISORDER 4 0.0002
759 INCORRECT DOSE ADMINISTERED 45 0.0002
760 PARAESTHESIA 31 0.0002
761 DISCOMFORT 12 0.0002
762 EAR DISCOMFORT 2 0.0002
763 MUSCULOSKELETAL CHEST PAIN 3 0.0002
764 VISUAL IMPAIRMENT 24 0.0002
765 HYPERBILIRUBINAEMIA 2 0.0002
766 POLLAKIURIA 8 0.0002
767 MUSCLE SPASMS 35 0.0002
768 SKIN EXFOLIATION 16 0.0002
769 PNEUMOTHORAX 3 0.0002
770 ULCER 3 0.0002
771 SURGERY 11 0.0002
772 BREAST PAIN 2 0.0002
773 BODY HEIGHT DECREASED 2 0.0002
774 IRRITABLE BOWEL SYNDROME 4 0.0002
775 HEREDITARY ANGIOEDEMA 2 0.0002
776 ASTHENIA 70 0.0002
777 JAUNDICE 5 0.0002
778 COLITIS 7 0.0002
779 FOETAL EXPOSURE DURING PREGNANCY 15 0.0002
780 SKIN LESION 5 0.0002
781 DRUG LEVEL INCREASED 3 0.0002
782 ABNORMAL DREAMS 5 0.0002
783 COAGULOPATHY 3 0.0002
784 MENTAL STATUS CHANGES 5 0.0002
785 COMPLETED SUICIDE 15 0.0002
786 TRANSAMINASES INCREASED 4 0.0002
787 FEELING COLD 5 0.0002
788 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
789 FACE OEDEMA 3 0.0002
790 CANDIDA INFECTION 3 0.0002
791 TARDIVE DYSKINESIA 5 0.0002
792 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
793 CONTUSION 17 0.0002
794 INTERNAL HAEMORRHAGE 2 0.0002
795 HYPOTENSION 35 0.0002
796 INFLAMMATION 9 0.0002
797 MUSCULOSKELETAL DISCOMFORT 3 0.0002
798 URTICARIA 29 0.0002
799 GENERAL PHYSICAL HEALTH DETERIORATION 20 0.0002
800 ELECTROLYTE IMBALANCE 2 0.0002
801 DRUG WITHDRAWAL SYNDROME 15 0.0002
802 ACUTE MYOCARDIAL INFARCTION 5 0.0002
803 BLOOD IRON DECREASED 2 0.0002
804 CEREBRAL HAEMORRHAGE 6 0.0002
805 HYPERSENSITIVITY 31 0.0002
806 PREMATURE BABY 5 0.0002
807 TOOTHACHE 3 0.0002
808 CONSTIPATION 36 0.0002
809 BURSITIS 2 0.0002
810 DYSURIA 6 0.0002
811 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
812 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
813 HYPONATRAEMIA 9 0.0002
814 FLATULENCE 9 0.0002
815 BRAIN OEDEMA 2 0.0002
816 ABDOMINAL PAIN LOWER 4 0.0002
817 PRODUCT COMPLAINT 4 0.0002
818 DIABETES MELLITUS 12 0.0002
819 PULMONARY OEDEMA 7 0.0002
820 VOMITING 73 0.0002
821 INFUSION SITE PAIN 2 0.0002
822 SWELLING FACE 10 0.0002
823 NEPHROLITHIASIS 7 0.0002
824 ANKYLOSING SPONDYLITIS 2 0.0002
825 DERMATITIS ATOPIC 8 0.0002
826 VIRAL INFECTION 5 0.0002
827 DYSPNOEA 85 0.0002
828 NEOPLASM MALIGNANT 10 0.0001
829 HOSPITALISATION 23 0.0001
830 ILL-DEFINED DISORDER 9 0.0001
831 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
832 FLUSHING 15 0.0001
833 BLINDNESS 6 0.0001
834 COMA 7 0.0001
835 DEPENDENCE 8 0.0001
836 CARDIO-RESPIRATORY ARREST 6 0.0001
837 DYSPEPSIA 14 0.0001
838 DEVICE OCCLUSION 2 0.0001
839 HYPOXIA 5 0.0001
840 EYE PAIN 8 0.0001
841 RETCHING 3 0.0001
842 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
843 INJECTION SITE HAEMATOMA 2 0.0001
844 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
845 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
846 GASTROENTERITIS 2 0.0001
847 DYSSTASIA 4 0.0001
848 INFLUENZA 15 0.0001
849 THROAT IRRITATION 6 0.0001
850 THERAPY NON-RESPONDER 6 0.0001
851 INTESTINAL OBSTRUCTION 5 0.0001
852 PANCREATITIS 7 0.0001
853 BRADYCARDIA 7 0.0001
854 INJECTION SITE RASH 4 0.0001
855 GYNAECOMASTIA 4 0.0001
856 DEHYDRATION 17 0.0001
857 MOBILITY DECREASED 9 0.0001
858 ABDOMINAL DISTENSION 13 0.0001
859 NIGHT SWEATS 4 0.0001
860 NEURALGIA 3 0.0001
861 MUSCULAR WEAKNESS 14 0.0001
862 BACK DISORDER 2 0.0001
863 LIVER INJURY 3 0.0001
864 EYE DISORDER 4 0.0001
865 BACK PAIN 28 0.0001
866 DRY EYE 6 0.0001
867 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
868 HEMIPARESIS 2 0.0001
869 HEPATIC ENZYME INCREASED 8 0.0001
870 HYPOPHAGIA 3 0.0001
871 SINUSITIS 12 0.0001
872 THERAPY CESSATION 6 0.0001
873 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
874 ANAPHYLACTIC SHOCK 3 0.0001
875 UNRESPONSIVE TO STIMULI 3 0.0001
876 HAEMATOMA 3 0.0001
877 DEAFNESS 3 0.0001
878 PRURITUS 44 0.0001
879 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
880 SKIN BURNING SENSATION 8 0.0001
881 RASH PRURITIC 6 0.0001
882 COMPLICATION OF DEVICE REMOVAL 2 0.0001
883 ARTHRALGIA 46 0.0001
884 MYOCARDIAL INFARCTION 19 0.0001
885 BACTERIAL INFECTION 2 0.0001
886 CARDIAC DISORDER 10 0.0001
887 SWELLING 10 0.0001
888 BLISTER 6 0.0001
889 RASH ERYTHEMATOUS 5 0.0001
890 BLOOD GLUCOSE DECREASED 5 0.0001
891 HERNIA 2 0.0001
892 MUSCULOSKELETAL STIFFNESS 9 0.0001
893 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
894 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
895 ALOPECIA 20 0.0001
896 BURNING SENSATION 7 0.0001
897 BLOOD POTASSIUM DECREASED 3 0.0001
898 NASOPHARYNGITIS 18 0.0001
899 HAEMOGLOBIN DECREASED 10 0.0001
900 ERYTHEMA 20 0.0001
901 INFLUENZA LIKE ILLNESS 8 0.0001
902 RHABDOMYOLYSIS 4 0.0001
903 HAEMORRHAGE 10 0.0001
904 CHILLS 11 0.0001
905 HYPOACUSIS 4 0.0001
906 RHINORRHOEA 6 0.0001
907 STAPHYLOCOCCAL INFECTION 3 0.0001
908 OEDEMA PERIPHERAL 11 0.0001
909 FUNGAL INFECTION 3 0.0001
910 ARTHROPATHY 5 0.0001
911 GAIT INABILITY 3 0.0001
912 EYE PRURITUS 3 0.0001
913 CHROMATURIA 2 0.0001
914 ASTHMA 10 0.0001
915 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
916 CARDIAC FAILURE 7 0.0001
917 THROMBOSIS 7 0.0001
918 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
919 EYE IRRITATION 5 0.0001
920 NASAL CONGESTION 5 0.0001
921 WHEEZING 5 0.0001
922 OCULAR HYPERAEMIA 4 0.0001
923 MULTIPLE SCLEROSIS 4 0.0001
924 STOMATITIS 5 0.0001
925 DRY SKIN 11 0.0001
926 INJECTION SITE URTICARIA 2 0.0001
927 EPISTAXIS 6 0.0001
928 PRODUCT STORAGE ERROR 7 0.0001
929 CELLULITIS 4 0.0001
930 PERIPHERAL SWELLING 12 0.0001
931 EXPOSURE VIA SKIN CONTACT 2 0.0001
932 DIPLOPIA 2 0.0001
933 INFUSION RELATED REACTION 5 0.0001
934 DIARRHOEA 48 0.0001
935 OEDEMA 4 0.0001
936 DYSPHAGIA 7 0.0001
937 LUNG NEOPLASM MALIGNANT 3 0.0001
938 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
939 DIVERTICULITIS 2 0.0001
940 RESPIRATORY FAILURE 5 0.0001
941 LIVER DISORDER 3 0.0001
942 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
943 INJECTION SITE SWELLING 5 0.0001
944 PNEUMONIA 21 0.0001
945 COUGH 18 0.0001
946 FALL 21 0.0001
947 DISEASE RECURRENCE 3 0.0001
948 NEUTROPENIA 8 0.0001
949 URINARY TRACT INFECTION 10 0.0001
950 JOINT SWELLING 7 0.0001
951 GAIT DISTURBANCE 11 0.0001
952 INJURY 4 0.0001
953 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
954 UNDERDOSE 4 0.0001
955 BRONCHITIS 4 0.0001
956 EYE SWELLING 2 0.0001
957 DYSPNOEA EXERTIONAL 2 0.0001
958 HOT FLUSH 4 0.0001
959 CONVULSION 3 0.0001
960 BONE PAIN 3 0.0001
961 INFECTION 7 0.0000
962 DEVICE DISLOCATION 2 0.0000
963 ANGIOEDEMA 2 0.0000
964 RHEUMATOID ARTHRITIS 5 0.0000
965 BREAST CANCER 4 0.0000
966 INJECTION SITE PAIN 13 0.0000
967 DISEASE PROGRESSION 5 0.0000
968 HYPOGLYCAEMIA 2 0.0000
969 FLUID RETENTION 2 0.0000
970 PSORIASIS 5 0.0000
971 BLOOD GLUCOSE INCREASED 7 0.0000
972 SEPSIS 4 0.0000
973 HERPES ZOSTER 2 0.0000
974 CATARACT 2 0.0000
975 INJECTION SITE ERYTHEMA 4 0.0000
976 NEUROPATHY PERIPHERAL 3 0.0000
977 ATRIAL FIBRILLATION 3 0.0000
978 FEBRILE NEUTROPENIA 2 0.0000
979 INJECTION SITE PRURITUS 2 0.0000
980 THROMBOCYTOPENIA 3 0.0000
981 ACUTE KIDNEY INJURY 4 0.0000
982 CARDIAC FAILURE CONGESTIVE 2 0.0000
983 RENAL FAILURE 3 0.0000
984 DEVICE ISSUE 2 0.0000
985 DEATH 17 0.0000
986 DRUG DOSE OMISSION 3 0.0000
987 ANAEMIA 3 0.0000